Cencora has appointed Samantha Hammock as Executive Vice President and Chief Human Resources Officer (CHRO), effective July 13, 2026. She succeeds Silvana Battaglia, who will retire from the company following a distinguished seven-year tenure. Battaglia will transition to a special advisor role on the same date and will work closely with Hammock through the end of the calendar year to ensure a successful transition.

Robert P. Mauch, President and Chief Executive Officer of Cencora, highlighted Battaglia's contributions to the company's culture and growth. "During her seven years of leadership, Silvana has made critical, lasting contributions to Cencora during a time of significant growth," said Mauch. "Her global vision strengthened our culture and championed meaningful progress in how we invest in and care for our team members."

Battaglia reflected on her tenure, noting the HR team's accomplishments in building a world-class employee experience for more than 51,000 team members. "I will leave knowing that our team members have the tools and resources they need to support Cencora's success in the years ahead," she said.

Leadership Transition Details

In her new role, Hammock will report to CEO Bob Mauch as a member of the company's enterprise leadership team. She will be responsible for setting and implementing Cencora's global human resources strategy. Mauch expressed confidence in Hammock's ability to advance the company's growth priorities. "Sam's experience leading human resources strategy at scale with technology-forward thinking and building high-performing teams make her a valuable addition to our team," he said.

Hammock joins Cencora from Verizon Communications, where she most recently served as Executive Vice President and CHRO. Prior to Verizon, she held various executive roles across HR at American Express, including serving as their Head of Global Talent and Learning.

Executive Profiles

Hammock emphasized her commitment to the company's purpose. "I am honored to join Cencora, a company whose purpose of creating healthier futures is reflected every day through its critical role at the center of the global pharmaceutical supply chain," she said. "I look forward to working with Bob and the leadership team to advance Cencora's workforce transformation, strengthen its culture and empower team members to grow, thrive and help shape the company's future."

Barclays analyst Glen Santangelo has maintained an Overweight rating on Cencora while lowering the price target to $350 from $425. The revised target suggests a shift in the stock's valuation expectations despite the continued positive stance.

Rating and Price Target Details

The decision to retain the Overweight rating indicates confidence in Cencora's performance relative to its sector peers. However, the reduction in the price target highlights a more conservative near-term outlook.

The adjustment comes as part of a routine review of the company's financial position and market conditions.